GLMDVSSLXN• 3 Months (Normalized)
GLMD vs SLXN (Galmed Pharmaceuticals Ltd. vs Silexion Therapeutics Corp)
Showing Closing Date Range from Jul 1 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GLMD Performance $3.63
+460.36%
Galmed Pharmaceuticals Ltd.
Normalized Baseline0.00%
SLXN Performance $0.32
+%
Silexion Therapeutics Corp
Normalized Baseline0.00%
Alpha Spread Margin GLMD LEADS
+460.36 pts
GLMD outperforming by 460.36 percentage points
GLMDSLXN
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GLMD SLXN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | GLMD Price | GLMD Gain (%) | SLXN Price | SLXN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 28, 2026 | $3.63 | +460.36% | $- | - | |
| Sep 25, 2026 | $3.63 | +460.36% | $- | - | |
| Sep 24, 2026 | $3.62 | +458.81% | $- | - | |
| Sep 23, 2026 | $3.62 | +458.81% | $0.32 | -87.81% | +546.62% |
| Sep 22, 2026 | $- | $0.39 | -84.84% | - | |
| Sep 21, 2026 | $3.50 | +440.29% | $0.54 | -78.96% | +519.25% |
| Sep 18, 2026 | $3.40 | +424.85% | $0.44 | -83.13% | +507.98% |
| Sep 17, 2026 | $3.48 | +437.20% | $0.38 | -85.30% | +522.50% |
| Sep 16, 2026 | $3.41 | +426.40% | $0.34 | -86.85% | +513.25% |
| Sep 15, 2026 | $3.63 | +459.59% | $0.34 | -86.85% | +546.44% |
| Sep 14, 2026 | $3.82 | +489.69% | $0.39 | -85.09% | +574.78% |
| Sep 11, 2026 | $3.84 | +492.78% | $0.36 | -86.19% | +578.97% |
| Sep 10, 2026 | $4.03 | +522.11% | $0.42 | -83.64% | +605.75% |
| Sep 09, 2026 | $4.63 | +614.73% | $0.35 | -86.46% | +701.19% |
| Sep 08, 2026 | $3.83 | +490.46% | $0.35 | -86.65% | +577.11% |
Page 1 of 5